Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Growing Impact

Growing Impact artwork

PFAS and human health

Mar 1, 202525 minAudio
ShareXLinkedInFacebookWhatsAppEmail

PFAS, synthetic chemicals found in countless everyday products, have made their way into humans and animals around the globe. Although their health effects remain unclear, their widespread presence raises important questions. Scientists are now investigating whether these chemicals might disrupt the human gut microbiome, potentially impacting our health in unexpected ways.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

Persistent chemicals are perhaps transiently or maybe even permanently altering the microbiome depending on the exposure window. So one of those big questions people have is if you're exposed early on in life and at birth, does this perhaps set your set you up in the wrong trajectory, if you will, health wise? Welcome to Growing Impact, a podcast by the Institute of Energy and the Environment at Penn State. Each month, Growing Impact explores the projects of Penn State researchers who are solving some of the world's most challenging energy and environmental issues.

Each project has been funded by the institute seed grant program that grows new research ideas into impact for energy and environmental solutions. I'm your host, Kevin Sleiman. Perfluorinated substances, also known as PFAS, are man made chemicals found in a wide variety of everyday items. They've been around since the nineteen forties, and widespread detection and public awareness increased significantly around the turn of the century. There is growing evidence of links between PFAS exposure and various health effects.

And these forever chemicals can now be found in many living creatures, including humans. On this episode of Growing Impact, we discuss a past seed grant on environmental contaminants through which researchers have continued to develop new areas of investigation. One of the important questions raised by this team of researchers is, do PFAS impact the human microbiome, which are the microorganisms that live in a human's gut? And if so, what's the impact?

Hello, Andrew. Hello, Costas. Hey, Kevin. How are you? Hi. How are you? I'm doing great. Thanks so much for being on Growing Impact and discussing your research. Could each of you take a moment and introduce yourselves? Can you tell us your name, your title, and provide a brief background on your research? I'm Andrew Patterson. I'm the John t and Paige s Smith professor in the College of Agricultural Sciences. My home department is the Department of Veterinary and Biomedical Sciences. I've been here at Penn State now since 2011,

and my research really focuses on the chemical communication between the host, most cases, mouse models, but also humans and their microbial partners, so the microbiome. So we've been really active in this area trying to, you know, dissect how we communicate with those microbes and vice versa. And so this has been the central focus of our research for, you know, the last thirteen years or so, and hence, kind of the strong connection that I've had with Costas to really focus on kind

of this important question, and that is around how microbes are utilizing substrates that the host provides and vice versa. So my name is Costas Maranas. I'm the Donald B. Rauton Professor of Chemical Engineering, and my home department is Chemical Engineering Department. And, our research work travels the world of biotechnology, biophysics, and biochemistry, with the world of computations, optimization, and algorithms. So what we are trying to do is figuring out ways of making

metabolic pathways more in tune with your biotechnology objective, finding ways to engineer enzymes, to do appropriate bioconversions, engineer antibodies so they recognize specific antigens, etcetera. So everything that we do in our group is, computation. Also, we are partnering with other labs either at Penn State or elsewhere to help us support our investigations. Your work on environmental contaminants and their impact on human health has continued to grow.

Can you tell us about the start of this effort and what inspired you to to research the subject? When I first came here to Penn State, one of my big interests has always been on understanding how chemicals that we're exposed to impacts us. And we had really only ever focused on this from the host perspective. So really thinking about this, you know, how do these chemicals impact us directly? But during my postdoc, when I was with Frank Gonzales at the National Cancer Institute, we we had some hints that it was impacting other things, like

the microbes that resided in us. But we really didn't have a lot of the tools and technology and, more importantly, the expertise to really investigate this in a lot of detail. So that was one of the very first things I did when I got here to Penn State was to do some basic sequencing experiments. Back this is now, gosh, probably right after I got here, so twelve, thirteen years ago. And that was to look at the community changes that were occurring after this exposure. In this case, it was a different drug. It was not an environmental contaminant. But we very quickly saw that there was a big impact

on the composition of the microbes, in this case, in the guts of mice. And that very quickly led us to try to focus on what that meant functionally. And so we started combining what is you know, what I'd say is our lab's expertise, and that's metabolomics. And so this is just a way of comprehensively profiling all the small molecules that are in a sample, so glucose, TCA cycle intermediates, bile acids, that sort of thing. And from there, we began to expand upon, you know, any other different type of chemical

that we may be exposed to. And so because we're in the Institute of Environment and Energy, one of the things we've been focusing on was, you know, thinking about these environmental chemicals, PFAS, perfluorinated species were on the you know, on everyone's radar even now more than ten years ago. Now currently, it's, you know, hugely important. But beyond that, also looking at other environmental chemicals, persistent ones, dioxins, furans, PCBs, these types of chemicals that we know to be exposed to on a daily basis. And one of the big things we began to wonder was, how is this impacting, you know,

this other important thing at the time was the microbiome? And I think it was relatively new, and so that's really what, you know, kind of sprung the whole interaction. Alright. So the contaminant at the time you've already mentioned was the PFOA. I don't know if everyone's familiar with that as PFOA, but under that PFAS kind of terminology. Could you tell us a little bit about it and maybe, you know, where it's used and what it's used for, maybe where it shows up. Over the last several years, we've been reading a lot about it in just the, you know, general,

you know, newspapers, magazines because it's been showing up in humans at barely reasonable levels. I don't think we have a good understanding of where at what level of the toxicity occurs. There's certainly some concerns about it because, you know, they would not expect them to be, you know, as, pervasive throughout humans, but also, I would say probably fairly easy to say that any organism on Earth probably has some level of these chemicals, residing in them. So where do they come from? You know, anything that's gonna be used for

water repellents, plastics, anything like our cell phones, all of these things that we utilize in our day to day lives require these chemicals, you know, for their production. Certainly, I think there's a big wish to move away from them in terms of, you know, waterproofing and that sort of thing. You know, nonstick, all that sort of stuff as well. But the problem is that they're really persistent in the environment. They don't break down as as readily. And so I think that's why we've been seeing them in, you know, in our bodies over the last, I think it's a question

about when. It's been probably as many decades. I think that we we know that they're there and, you know, there's been a lot of work to show that samples collected prior to their production, you know, nothing is there. So this isn't some accident of the involve, you know, nature. This is clearly a activity of humans. So they've been, you know, huge efforts now to comprehensively profile them. So this now, you know, I think where people are just looking at a few. So PFOS, PFOA. Now there's I don't even know what the number is now, but probably dozens in their

metabolites too. So I think that's raised a lot of questions. And then, you know, I think there's a lot of issues with you know, if we try to think about these as being foreign chemicals, you know, we should probably keep them, you know, to almost zero levels in us. And the fact that now pretty much everybody on Earth has them, and they're finding them in places that are so remote, you know, this is just being shown that they're being carried, you know, by a variety of different, you know, atmospheric processes, that sort of thing. It's it's raised a lot of concern. And the question then is, you know, what are

the long term health implications of this? And I think the I I don't think there's been a clear connection yet. A lot of it's been done through animal models and then, of course, maybe through epidemiological studies. But the you know, I think this is, you know, something that we'll we'll begin to figure out here in the next, you know, few years about what this what this means long term. And I think that, you know, the question about people are certainly afraid of it. So, I think we just gotta figure out what it really means in terms of, you know, are these exposures causing problems or not? I don't think we really know the answer to that yet or not. How

does PFOA impact human health? So it's still an unknown at this point. There are conjectures. Right? There's theories and models that maybe are out there, but there's no clear evidence. Am I understanding that correctly on how it affects humans? Yeah. I I'd say it's it's not totally murky. I think we have a sense that there's some impact. What I don't think is clear is, like, the exact mechanism by which things may cause harm. And more importantly, I think with respect to toxicology, it's like an understanding of, you know, what the dose is and what a typical

dose is for you and I and how that actually translates into, you know, what we would consider, you know, something that would cause toxicity. So, you know, this has always been a big, you know, central tenet of toxicology, and that's the dose makes the poison. And so it's something I think we we need to wrestle with, but I think I would go as far as to say we're just not exactly a % sure of what these long term health implications are. Yeah. Very some epidemiological evidence that tends to increase these outcomes. But, again, those are only epidemiological data with plenty of compounders

either people are exposed to poofus, or older, exposed to other industrial poisons. So the question is, you know, as Andrew mentioned, what is the cause of your mechanism? And we don't it's my knowledge. We still don't know that. Those molecules are designed to be incredibly stable and nonreacting, so they are by design that don't interfere with life's chemistry very much. But, of course, when they stop building up at high abundances, you you you don't know what would happen.

Yeah. And I think the big question is is that it's hard to pinpoint one chemical that's causing the problem. So as Costa said, you know, it's it's much more complicated because we are exposed to a you know, it's a mixtures problem. And so what do all those mixtures of chemicals actually do? And is the mixture that I'm exposed to similar to what you you guys may be exposed to? And it could just it could be specific to the individual being ex you know, that the exposure is occurring to. And, of course, all the other things, you know, the big one is, of course, you

know, diet, health, you know, or exercise. All these other factors play an important role in in this, and so we're, you know, trying to disentangle that. It's easy to do in mice, right, because we can control them really easily. We know what we feed them. We know how active they are. We can even control, you know, some of those aspects really relatively easily. But for, you know, your free range and human, that's really challenging to do. How have you seen this effort grow and mature since it started? Again, we're looking back, like, a decade. Some of the things that have changed and or grown?

Yeah. I think one of the interesting observations we made early on with this and a and a variety of other environmental contaminants was their impact on bile acid metabolism. So these are molecules that, you know, if we look in our textbooks are important for fat solubilization after you eat a meal. But what we quickly realized was that, you know, these were good readout of changes in microbial activity, enzymatic activity in particular. And that was one of the questions I actually had brought up to Costas' group was, you know,

we we can see these changes occurring in the bile acid pool. In particular, we could see changes in the way bile acids are decorated with different amino acids. And so one of the things we began to wonder was why? What is it? What is going on here? And for probably decades, people just thought this was a way to reduce their toxicity. So they microbes deconjugate. They're removing amino acids from them, in this case, glycine or taurine. And the big question was, well, why? And I I I couldn't really get a clear answer from that by looking in the literature.

So then I had talked to Costas about this, and Costas, I believe, is Joshua. That's is that right? Joshua Chang. Yes. My former post doc is now in a system professor at Colorado State. Yeah. So we started working together to try to figure out what this meant. And, actually, through this collaboration, Joshua was able to find, you know, some really interesting hypotheses that were outside of kind of the toxicity question. So really having to do with perhaps that, you know, the microbes could utilize these as energy sources.

And I think that was where it very quickly, you know, morphed into this, you know, understanding of, like, how our microbes are then responding to these changes, and then more importantly, how can we model this? And that was really hard. I mean, it's not something my group is is at all familiar with, but the expertise that we had, you know, with Costas' group really allowed us to address this question. And then Costas, I actually I think it was after this paper, then we worked with Gary Wu more on that neonatal thing. And this is, again, the same type of thing. Like, how do we begin to integrate the changes that we see in the microbial

community from, say, just like if we're just counting who's there versus what we see when we measure their metabolites through metabolomics? We didn't have a really good way of integrating that data, and that's where, you know, our interaction collaborations with Casas Group had a huge impact because that started to allow us to put these pieces of the puzzle together in a way that actually, you know, made some some sense. So that was a really, you know, tremendous, you know, finding that we we found through, you know, this collaboration. I think that's, you know, kind of where things have gone from this initial, seed grant.

Yeah. That John Sorg, he did a very nice work. He developed metabolic models for for many of the particular parts of the micro microbiome. They have the microbes that are present in there, and he asked the question, which carbon molecule can be consumed by what microbe? And then he ended up generating a hypothesis as to, you know, who is consuming what carbon molecule, and and why what purpose. And he continued on the same path of modeling microbial communities, and right now, he's running

his own lab. He's assistant professor at Colorado State. So I think that that had an impact in his career. Where has the c grant led you, and can you share some success stories? You know, this work that Joshua, helped us with, you know, obviously led, you know, to impart to his landing a faculty position. We also published a number of papers. One was in m systems. We subsequently Costas and I then focused on more around the, in this case, not so much the environmental contaminant aspect, but focusing on more of

the mechanism of how the microbes interact with host metabolites. So we wrote a grant with, some partners at NIH to look at in this case, this is a a more basic question around how this whole interaction occurs. So that was a win for us. And I think now coming full circle, we started working back on some of this, perfluorinated, work. And because of some of the insights we had originally, now we have some really amazing observations. It raises some important questions, and that is

that, is this exposure to these perfluorinated chemicals shifting our microbiome in a way that may be good or bad? We don't know. I'm not I'm not saying that it's a it's a health benefit of this exposure, but we don't really necessarily know what the change in that composition of that community. It may make you susceptible to certain things, like inflammatory bowel disease. Right? This is hugely problematic here across the westernized world. And so exposure to things like this could trigger trigger this. And I think this is something that,

from a toxicology standpoint, we've not really fully considered over the last, you know, I'd say, you know, many decades thinking as microbes as targets for toxicity endpoints. It's you know, there's no like, I can look at my, you know, toxicology textbooks, and there's no section on the microbiome. I mean, I think this is something that probably will be added, because now we appreciate that this is really important, and and we need to have a better understanding for how this whole, interaction occurs. And I think this is which so which is super exciting about the field right now. What are some next steps for the research? And

maybe looking at things that you're either excited about or even maybe some challenges? Yeah. I mean, I think the as I alluded to before, I think one of the things that we're really interested in is thinking about how these persistent chemicals are perhaps transiently or maybe even permanently altering the microbiome depending on the exposure window. So one of those big questions people have is if you're exposed early on in life, you know, at birth, does this perhaps set your set you up in the wrong trajectory, if you will, health wise?

And there's been a lot of evidence with that with antibiotics. So antibiotic exposure. Right? So that's you know, they know there's good evidence to show that this causes problems. The same can be true for these chemicals. Right? So, you know, they could be, you know, bactericidal, bacteriostatic, and they can have the same properties or, you know, you know, we may not be taking them for therapeutic purposes. Right? But if they're manipulating or altering the community in a way that sets you up in a, you know, kind of in a problematic way, I don't wanna say dysfunctional because

I don't really it's hard to say what that actually means. But it it is it is perhaps a a a contributor to some of our more modern health problems. I mean, I think that's, you know, something that people are trying to tease out. So I I'm excited about that because I think here, Penn State, we have the tools to do this. We now are doing really cool imaging studies to look at the individual bacteria themselves. This is something I never really would have thought to do, but, was only I only learned about it through

talking to someone at a at a networking thing one time where we were just sitting around talking about projects, and they said, oh, you should try this. So that's something that we've we've begun to explore now. And that's actually trying to image bacteria and to see what happens to them after certain exposures. And so you can do this by mass spec imaging now. There's other there's other platforms to do that. So I'm super excited about that. And, I think, you know, because we have all the right connections and we can you know, we have a track record of doing good stuff with everyone here. So

I think that's, really sets everyone up for success. And I gotta say, I think the big thing is the excitement really builds around seeing the students get excited about their projects. I mean, I I could speak for myself. Maybe Casas will agree. Like, most of the time I spend in my office, not doing very much in the lab at all. And but to hear them come in and share something exciting, I mean, I think that's that's probably the best, you know, most rewarding aspect of our jobs is to see them get excited about stuff. Yep. Ultimately, the the students tried the projects

where they are cooperating with good idea, but, you know, they they are the ultimate drivers of success or failure in all those collaborations. How did early support from IEE enable success in this project? One of the things that they were really adamant about was that you worked with someone outside of your college. And so that was, I think, another reason why Costas and I ended up working too, not just because of that reason, but I think that's made it a good fit. And, you know, I think that that really gave us a kind of a

well, provide us a really good complimentary, collaboration where, you know, we brought really both groups brought a lot of strengths to the table. And because of that kind of caveat that was within IE, solicitation, I think that was great. I mean, perhaps maybe there was some luck involved that we've that we just happened to work together at the right time, but I think because of that push, you know, that was that was really helpful. And I think that's something that IE is still championing, and I think other institutes, the HUC, for example, I know that they really favor that a lot, making sure

that you're not just sticking to your home department, but that you're working outside of that. And then, personally, it's just something that I really embrace, you know, through our work as well because I know that we're not experts in, you know, everything and that we do need help for doing things. And I think that makes things really fun. That makes research, you know, really enjoyable. Was there something that was surprising to you during this process that you, you know, learned or discovered? I think one thing that's come from just this general question is that

Al is probably a no brainer to cost us, but to me, it has been. And that was that how incredibly what good chemist microbes are. It's remarkable what we see. And, in fact, a lot of the things that we measure in our mass specs, you know, we can't annotate because they're not in some library. But we have a really strong feeling and and maybe even a good appreciation that a lot of what we're seeing is not through host, mediated mechanisms, but probably through microbial.

So I would say that's been maybe the biggest surprising thing, you know, to me. Yeah. My microbes do bring to bear so many more enzymes than the host has, mammalian host has. So, yeah, you should think of really that matter. It's not surprising. You think of a pound or so of of microbes could do so much, but every single one comes in with its own armory of metabolic functions and enzymatic functions. And my feeling is that we only understand part

of them. I think you start seeing compounds that when you do your MS, that you have no pathways that can explain them. So clearly there is more chemistry we can do than we, we know at this point. If you had twenty seconds, you're in an elevator with US Senator, you gotta pitch this project because you think it's the next best thing that you want them to champion it. What's your elevator pitch for this? Is it gonna be an eight year old senator? If that's the case, then I will tout the potential of this work towards extending

lifespan span, are manipulating their microbiome in their in their gut and understanding how that can have a age prolongation effect. Yeah. And I guess I mean, I would echo the same thing. I think that, you know, there's a lot of opportunities for drug development, you know, trying to understand how they may be producing important drugs because they produce thing you know, chemicals that manipulate us really, really well. There's lots of evidence of this. And so if we can tap into that and get a better understanding for how this occurs, you know,

there's, you know, huge rewards there from a, you know, therapeutic standpoint to promote our health, you know, reduce disease, and I think, ideally, improve, nutritional outcomes, you know, trying to understand, you know, what we're feeding us in addition to our microbes. Like, how does that impact overall health? So I think that's another key component there, and we didn't touch on today, but is nutrition and diet. You know, diet plays a huge role in shaping our microbial community, and so we can get a better sense of how that's working. You know, I think that this could have really profound, implications for, you

know, human health. There's a lot of people studying some of these long lived, Japanese, individuals who, by and large, live perfectly healthy lives well into their, you know, early hundreds. And so why is that? And one of the things one of the tantalizing things is is that this is a contribution of the microbes, preventing them from some really, you know, problematic diseases. It's interesting. Certainly, there's a lot to be learned, and I think, you know, like I said earlier on, that's good that's good for us because it just means that there's

more things for us to continue to work upon. Thank you for taking time and speaking with us. So, Kostas, Andrew, it was a great conversation. If anyone's interested in following up, certainly, my contact information is on the web, so you can always look me up. Alright. That wraps up our time. Thank you so much for being on Growing Impact. Alright. Thanks. This has been season five, episode six of Growing Impact. Thanks again to Andrew Patterson and Costas Moranis for speaking with me about their project. To watch a video version of this episode

and to learn more about the research team, visit iee.psu.edu/podcast. Once you're there, you'll find previous episodes, transcripts, related graphics, and so much more. Our creative director is Chris Komletic with graphic design and video production by Brenna Buck, marketing and social media by Tori Naviro, and web support by John Stavanger. Join us again next month as we continue our exploration of Penn State research and its growing impact. Thanks for listening.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Can plants detect PFAS?

    Nov 2, 202623 minAudio

    Plants respond to changes in their environment, but can those responses help detect contamination? A new research project is exploring whether flexible sensors attached to plants can identify electrical signals...

    Credit the people on this episode

  2. Plastic recycling with coal

    Oct 5, 202620 minAudio

    Plastic recycling is difficult for a simple reason: Plastics are designed to last. Penn State researchers are testing whether tiny particles of Pennsylvania anthracite coal can absorb laser light and deliver targeted...

    Credit the people on this episode

  3. Resilient power grid planning

    Jul 1, 202623 minAudio

    As electricity demand grows and becomes harder to predict, power grid planners face a difficult question: how do they build for a future shaped by extreme weather, renewable energy, and the rapid rise of data centers? A...

    Credit the people on this episode

  4. Managing India's groundwater crisis

    Apr 1, 202625 minAudio

    India is the world's largest groundwater-based economy, with more than half its 1.5 billion population depending on agriculture for their livelihoods - making groundwater depletion a critical threat. Researchers are...

    Credit the people on this episode

  5. Microplastics in the marsh

    Feb 1, 202621 minAudio

    Microplastics are turning up in unexpected places, including tidal freshwater marshes. Researchers are uncovering how these ecosystems trap plastics before they reach the ocean, leading to long-term accumulation in...

    Credit the people on this episode